Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review

Clinical Therapeutics

Volumn 31, Issue 9, 2009, Pages 1977-1986

  Hung, Yuan Pin ^a,b   Lee, Nan Yao ^a   Chang, Chia Ming ^a   Lee, Hsin Chun ^a,c   Wu, Chi Jung ^a,b   Chen, Po Lin ^a   Lee, Ching Chi ^a,b   Chung, Chih Huan ^a   Ko, Wen Chien ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

adverse drug reaction; allergic reaction; drug fever; neutropenia; rash; teicoplanin; vancomycin

Indexed keywords

TEICOPLANIN; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BODY WEIGHT; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE COMPARISON; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXFOLIATIVE DERMATITIS; FEMALE; FEVER; HOSPITAL PATIENT; HUMAN; KIDNEY DISEASE; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MEASLES LIKE RASH; MEDICAL RECORD REVIEW; NEUTROPENIA; PAPULAR RASH; RASH; RESPIRATORY TRACT INFECTION; SEX DIFFERENCE; THROMBOCYTOPENIA; TREATMENT DURATION; VESICULAR RASH; WOUND INFECTION;

EID: 72149086021     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.09.010     Document Type: Article

References (31)

1. Corey G.R. Staphylococcus aureus bloodstream infections: Definitions and treatment. Clin Infect Dis. 48 Suppl 4 (2009) S254-S259
2. Kirby W.M. Vancomycin therapy of severe staphylococcal infections. J Antimicrob Chemother. 14 Suppl D (1984) 73-78
3. Gruchalla R.S., and Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med. 354 (2006) 601-609
4. Wood M.J. The comparative efficacy and safety of teicoplanin and vancomycin [published corrections appear in J Antimicrob Chemother. 1996;38:919 and J Antimicrob Chemother. 1997;40:147]. J Antimicrob Chemother 37 (1996) 209-222
5. Hsu S.I. Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy. 21 (2001) 1233-1239
6. Hannah B.A., Kimmel P.L., Dosa S., and Turner M.L. Vancomycininduced toxic epidermal necrolysis. South Med J. 83 (1990) 720-722
7. Perrett C.M., and McBride S.R. Teicoplanin induced drug hypersensitivity syndrome. BMJ. 328 (2004) 1292
8. Kwon H.S., Chang Y.S., Jeong Y.Y., et al. A case of hypersensitivity syndrome to both vancomycin and teicoplanin. J Korean Med Sci. 21 (2006) 1108-1110
9. Grek V., Andrien F., Collignon J., and Fillet G. Allergic crossreaction of teicoplanin and vancomycin. J Antimicrob Chemother. 28 (1991) 476-477
10. Davey P.G., and Williams A.H. A review of the safety profile of teicoplanin. J Antimicrob Chemother. 27 Suppl B (1991) 69-73
11. Schlemmer B., Falkman H., Boudjadja A., et al. Teicoplanin for patients allergic to vancomycin. N Engl J Med. 318 (1988) 1127-1128
12. McElrath M.J., Goldberg D., and Neu H.C. Allergic cross-reactivity of teicoplanin and vancomycin. Lancet. 1 (1986) 47
13. Hsiao S.H., Chang C.M., Tsai J.C., et al. Glycopeptideinduced neutropenia: Cross-reactivity between vancomycin and teicoplanin. Ann Pharmacother. 41 (2007) 891-894
14. Khurana C., and de Belder M.A. Red-man syndrome after vancomycin: Potential cross-reactivity with teicoplanin. Postgrad Med J. 75 (1999) 41-43
15. Marshall C., Street A., and Galbraith K. Glycopeptide-induced vasculitis-cross-reactivity between vancomycin and teicoplanin. J Infect. 37 (1998) 82-83
16. Prey S., Sparsa A., Boumediene A., et al. Cutaneous drug reactions induced by glycopeptides [in French]. Med Mal Infect. 37 (2007) 270-274
17. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 30 (1981) 239-245
18. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf Accessed January 24, 2009
19. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 67 (2005) 2089-2100
20. Farber B.F., and Moellering Jr. R.C. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother. 23 (1983) 138-141
21. Morris A., and Ward C. High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit. J Infect. 22 (1991) 217-223
22. Pai M.P., Mercier R.C., and Koster S.A. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann Pharmacother. 40 (2006) 224-228
23. Segarra-Newnham M., and Tagoff S.S. Probable vancomycininduced neutropenia. Ann Pharmacother. 38 (2004) 1855-1859
24. LeFrock J., and Ristuccia A. Teicoplanin in the treatment of bone and joint infections: An open study. J Infect Chemother. 5 (1999) 32-39
25. Pauluzzi S., Del Favero A., Menichetti F., et al. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: An open study. J Antimicrob Chemother. 20 (1987) 431-438
26. Calain P., Krause K.H., Vaudaux P., et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis. 155 (1987) 187-191
27. Sanche S.E., Dust W.N., and Shevchuk Y.M. Vancomycin-induced neutropenia resolves after substitution with teicoplnin. Clin Infect Dis. 31 (2000) 824-825
28. Asero R. Teicoplanin-induced anaphylaxis. Allergy. 61 (2006) 1370
29. Smith P.F., and Taylor C.T. Vancomycininduced neutropenia associated with fever: Similarities between two immune-mediated drug reactions. Pharmacotherapy. 19 (1999) 240-244
30. Schwartz M.D. Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody. Pharmacotherapy. 22 (2002) 783-788
31. Rocha J.L., Kondo W., Baptista M.I., et al. Uncommon vancomycin-induced side effects. Braz J Infect Dis. 6 (2002) 196-200